Epigenetic "readers" that recognize defined posttranslational modifications on histones have become desirable therapeutic targets for cancer and inflammation. SP140 is one such bromodomain and plant homeodomain (PHD)-containing reader with immune-restricted expression, and single-nucleotide polymorphisms (SNPs) within SP140 associate with Crohn's disease (CD). However, the function of SP140 and the consequences of disease-associated SP140 SNPs have remained unclear. We show that SP140 is critical for transcriptional programs that uphold the macrophage state. SP140 preferentially occupies promoters of silenced, lineage-inappropriate genes bearing the histone modification H3K27me3, such as the HOXA cluster in human macrophages, and ensures their repression. Depletion of SP140 in mouse or human macrophages resulted in severely compromised microbe-induced activation. We reveal that peripheral blood mononuclear cells (PBMCs) or B cells from individuals carrying CD-associated SNPs within SP140 have defective SP140 messenger RNA splicing and diminished SP140 protein levels. Moreover, CD patients carrying SP140 SNPs displayed suppressed innate immune gene signatures in a mixed population of PBMCs that stratified them from other CD patients. Hematopoietic-specific knockdown of Sp140 in mice resulted in exacerbated dextran sulfate sodium (DSS)-induced colitis, and low SP140 levels in human CD intestinal biopsies correlated with relatively lower intestinal innate cytokine levels and improved response to anti-tumor necrosis factor (TNF) therapy. Thus, the epigenetic reader SP140 is a key regulator of macrophage transcriptional programs for cellular state, and a loss of SP140 due to genetic variation contributes to a molecularly defined subset of CD characterized by ineffective innate immunity, normally critical for intestinal homeostasis.
INTRODUCTION
The epigenome is essential for generating signal-specific, cell lineagespecific, and kinetically precise gene expression in diverse cell types. Modifications on histones control the accessibility of DNA to transcription factors and serve as docking sites for epigenetic "reader" proteins that aid the assembly of transcriptional machinery complexes (1) (2) (3) (4) . Disruption of numerous epigenetic proteins culminates in malignant disease (5); however, our understanding of the role of altered epigenome regulators in nonmalignant, immune-driven disorders is relatively limited.
Epigenetic readers are structurally diverse proteins with evolutionarily conserved domains that dock to covalent modifications of histones, DNA, or transcription factors (6) (7) (8) . They hold great promise as therapeutic targets in cancer and inflammation. For instance, members of the broadly expressed BET [bromodomain (the interaction module that reads -N-acetylation) and extraterminal] family perform central roles in translating histone modifications into context-specific transcription in cancer cells (9, 10) , macrophages (1, 3, 11) , and T cells (12, 13) ; show remarkable therapeutic tractability (3, 9) ; and are under investigation in several clinical trials (7, 14) . However, the human proteome contains 46 bromodomain-containing proteins, each with defined affinities to certain histone acetylation sites (8) , distinct tissue expression patterns, and unique protein interactors (4)-many of which remain uncharacterized. The bromodomain-containing protein SP140 is preferentially expressed in cells of the immune system (15) , suggesting an immunespecific role for this epigenetic reader. Moreover, single-nucleotide polymorphisms (SNPs) within SP140 have been significantly associated with immune disorders, such as Crohn's disease (CD) (16, 17) , B cell chronic lymphocytic leukemia (CLL) (18) , and multiple sclerosis (MS) (19), and autoantibodies against SP140 have been detected in patients with primary biliary cirrhosis (20) . Despite these findings, the function of SP140 and the consequence of disease-associated SP140 SNPs have remained unknown.
SP140 belongs to the speckled protein (SP) family consisting of SP100, SP110, and SP140L, which have high sequence homology with the Autoimmune Regulator (AIRE) (21) . SP family members are components of promyelocytic leukemia nuclear bodies (PML-NBs), which are ill-defined subnuclear structures regulated by a variety of cellular stresses [such as virus infection and interferon (IFN) and DNA damage], with implicated roles in many cellular processes, including higherorder chromatin organization (22) . SP140 has several features indicative of a transcriptional regulator: an N-terminal HSR domain, a SAND
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domain [named after the few proteins (namely, SP100, AIRE, NucP41/ P75, and DEAF) that have it] that interacts with DNA directly or through protein-protein interaction (23, 24) , a plant homeodomain (PHD) that docks to histone methylation, and a bromodomain that binds acetylated histones (8) . A potential transcriptional activator role for SP140 has been proposed (25) .
Inflammatory bowel disease (IBD), including CD, is a complex disease involving inflammation of the gastrointestinal tract that is triggered by genetic, environmental, and possibly epigenetic factors (26, 27) . Genome-wide association studies have identified more than 160 IBD-associated genetic variants (16) , some of which have revealed the importance of competent and protective bacterial defense pathways elicited in response to commensal microbes in controlling intestinal homeostasis (26, (28) (29) (30) (31) . In this study, we investigated how an IBD-associated genetic variant of the epigenetic reader SP140 might impinge on defense responses to microbes that determine intestinal homeostasis.
We show that SP140 is a key orchestrator of transcriptional programs that support macrophage activation state attained in response to cytokines and microbes, through repression of lineage-inappropriate genes, including HOX genes. These SP140-dependent transcriptional programs are indispensable for intestinal and immune homeostasis, as the loss-of-expression consequences of CD-associated SP140 SNPs we identified led to significantly suppressed innate immune gene signatures in a mixed population of peripheral blood mononuclear cells (PBMCs), which stratified CD patients carrying SP140 SNPs from other CD patients not harboring SP140 polymorphisms. Furthermore, hematopoietic-specific depletion of Sp140 in mice led to exacerbated dextran sulfate sodium-induced (DSS) colitis, and low SP140 levels in human intestinal tissue correlated with relatively lower innate cytokine levels in diseased intestinal tissue and improved response to antitumor necrosis factor (TNF) therapy.
Thus, the epigenetic reader SP140 is central to the regulation of macrophage transcriptional programs critical to the establishment of intestinal homeostasis. This role of SP140 has direct relevance to human disease since a loss of SP140 by human genetic variation contributes to the development of CD.
RESULTS

SP140 is critical for mouse and human macrophage transcriptional programs
With the initial aim of identifying bromodomain-containing epigenetic readers that preferentially regulate immune cell function, we found SP140 to be selectively expressed in cells of the immune system (Fig. 1A ) (15) , with greatest abundance in mature B cells, dendritic cells, macrophages, and granulocytes and low amounts in hematopoietic stem cells (HSCs), monocytes, and T cells ( fig. S1 ). SNPs within SP140 have been associated with CD (16, 17) , and SP family members have previously been identified as IFN-stimulated genes (ISGs) (32, 33) . We therefore examined a potential role for SP140 in innate immune responses and inflammation. We found that SP140 expression was high in both human M(IFN-) and mouse M[IFN- + lipopolysaccharide (LPS)] or M(LPS) macrophages, low in M[interleukin-4 (IL-4)] macrophages (Fig. 1, B and C), and up-regulated upon Toll-like receptor 2 (TLR2) or TLR4 activation ( Fig. 1D and fig. S1 ). Short hairpin RNA (shRNA)-mediated knockdown of Sp140 in mouse macrophages resulted in a significant down-regulation (P < 0.05, >1.5-fold) of almost 50% of all LPSinduced genes (Fig. 1E, fig. S2 , and table S1), including transcripts that typically characterize M(LPS) activation status, such as the cytokines Il6, Il1a, Il15, Tnfsf4, and Tnfsf15 and the chemokines Cxcl10, Cxcl2, Ccl5, Ccl2, Ccl7, Ccl17, and Cxcl4. The transcription factors Nfkb2, Rel, Ear2, Ear3, and Ear10 and the chromatin modifiers or remodelers Arid2, Hdac2, and Setd3 were also significantly down-regulated ( Fig. 1E and table S1 ). A transient, small interfering RNA (siRNA)-mediated knockdown of Sp140 with three separate siRNAs or a pool of four siRNA sequences in terminally differentiated macrophages (Fig. 1F, looks like fig. S2C , and Fig. 1G ) also led to a significant reduction in Il6, Tnf, and Ifnb1 transcripts after LPS stimulation (Fig. 1G and fig. S2 ) as well as IL-6 and TNF protein production ( fig. S2) . Similarly, SP140 knockdown with a pool of four different siRNA sequences in human peripheral blood-derived macrophages resulted in a significant down-regulation of cytokines and cytokine receptors (TNF, TNFSF9, CSF1, CSF3, IL3RA, and IL1RN), chemokines (CCL1, CCL20, and XCR1), and transcription factors (SMAD7, SMAD1, and NFATC1) typically seen in LPS-induced macrophages differentiated with macrophage colony-stimulating factor (M-CSF) and IFN- ( Fig. 1H and table S2 ). We also saw an uncharacteristic up-regulation of T cell receptor components (CD3E, CD3D, CD3Z, CD247, and ITK) in SP140 knockdown M(IFN-+LPS 4h) macrophages. This suggests that without SP140, correct macrophage identity or reprogramming under M-CSF/IFN-/LPS differentiating and activating conditions is significantly deviated. Gene set enrichment analysis (GSEA) of SP140-dependent genes revealed a significant down-regulation of a number of inflammatory or innate immune gene set signatures upon SP140 knockdown and an up-regulation of Myc, E2F, and oxidative phosphorylation gene sets, where the latter is normally down-regulated because of the induction of aerobic glycolysis upon pathogen stimulation of macrophages ( Fig. 1I ) (34) . Furthermore, ineffective activation of human macrophages with SP140 deficiency was confirmed by quantitative polymerase chain reaction (qPCR) of IL6 and TNF transcripts in TLR4-stimulated macrophages from five independent donors (Fig. 1J) . Thus, SP140 is a critical regulator of TLR4-induced transcriptional programs in mouse and human macrophages, and compromised SP140 expression results in a significantly altered state of macrophage activation.
SP140 occupies transcriptional start sites in human macrophages
Bromodomain-containing proteins associate with chromatin by binding to acetylated histones or transcription factors (6) (7) (8) . The SP140 bromodomain has a high but nonselective affinity for multiple acetylated histone peptide sites in vitro (8) . However, SP140 also contains a SAND domain predicted to interact with DNA directly or through proteinprotein interaction (23, 24) and a PHD that reads methylated histones ( Fig. 2A) . However, the PHD of SP140 may be atypical (35, 36) . Nevertheless, there is no evidence to date demonstrating an association between SP140 and chromatin in cells. We conducted chromatin immunoprecipitation coupled with high-throughput sequencing (ChIP-seq) experiments to determine the global occupancy of endogenous SP140 in primary human macrophages M(IFN-) and M(IFN-+LPS 4h). This revealed a majority of SP140 occupancy at promoters (58.0%), defined as 5 kb upstream and downstream from the transcriptional start site (TSS) (Fig. 2B) . SP140 was also found at enhancers (11.5%) [defined as regions greater than 5 kb from a TSS and marked with either H3K27ac or H3K4me1, or both (37)], within gene bodies (20.7%), and at distal intergenic regions (9.8%) (Fig. 2B) , all of which did not change significantly upon the addition of LPS for 4 hours ( fig. S3 ). Rank ordering of 
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promoter SP140 occupancy in unstimulated and LPS-stimulated M(IFN-) macrophages revealed SP140 enrichment precisely at the TSS (Fig. 2C ). The rank ordering of genes occupied by SP140 was altered upon LPS stimulation, but the TSS location was not ( fig. S3 ). We next established a chromatin landscape for SP140 in human macrophages by using publicly available human macrophage ChIP-seq data for H3K4me3 to identify active or poised promoters, H3K27me3 to represent transcriptionally repressed regions, and H3K27ac or H3K4me1 to identify enhancers. Analysis of SP140 enrichment data as a metagene centered on the TSS revealed spatial colocalization of SP140 with H3K4me3 and H3K27me3 in promoters (Fig. 2D) . We saw co-occupancy of promoter-bound SP140 (defined as peaks within TSS ± 5 kb) with H3K4me3 or H3K27me3 peaks, with more than 50% of all promoter-bound SP140 overlapping (within 0.5 kb) with regions marked by H3K4me3, H3K27me3, or a combination of these ( fig. S4 ).
We also observed SP140 overlap at inactive and active enhancers bearing H3K27ac, H3K4me1, or both marks ( Fig. 2D and fig. S4 ) but no enrichment at "super-enhancers," as defined by regions with the highest ranking of H3K27ac ( fig. S5 ) (38) . These results indicate that SP140 interacts with chromatin predominantly at gene promoter regions or TSS in human macrophages.
SP140 occupies repressed genes bearing H3K27me3 with inaccessible chromatin
Changes in H3K27me3 and H3K4me3 ratios on bivalent chromatin domains not only underlie cell-specific gene expression during differentiation but also enable fine-tuning of gene expression in differentiated cells (39) . Therefore, we next examined quantitative relationships between SP140 and H3K27me3 or H3K4me3 in human macrophages. SP140 enrichment (ChIP-seq tag counts) positively correlated with H3K27me3 enrichment, with regions of highest SP140 occupancy being concentrated at high H3K27me3 and low H3K4me3, considered to be loci with low transcriptional activity ( = 0.58; P < 1 × 10 −16 ) (Fig. 2, E and F) . A correlation analysis of SP140 peak signal compared with ranked H3K27me3 ChIP peak signal values in human M(IFN-) and M(IFN-+LPS 4h) confirmed these findings ( = 0.64; P < 2.2 × 10 −16 ) ( fig. S6 ). We next performed assays for transposase-accessible chromatin (ATAC-seq) (40) in human M(IFN-) and M(IFN-+LPS 4h) macrophages and found that genes with the greatest SP140 occupancy (top 10% of SP140 ChIP peaks) showed markedly reduced chromatin accessibility at promoters compared with genes with low SP140 occupancy (bottom 10% of SP140 ChIP peaks) (Fig. 2G) . We observed a similar trend of reduced chromatin accessibility at regions of high H3K27me3, a known repressive modification ( fig. S7 ). Thus, SP140 preferentially occupies repressed genes with inaccessible chromatin and high H3K27me3 in human macrophages.
SP140 represses macrophage lineage-inappropriate genes, including HOX genes
To understand the functional significance of SP140 occupancy, we used the Genomic Regions Enrichment of Annotations Tool (GREAT) (41) and found the top gene families occupied by SP140 in human macrophages to be macrophage-inappropriate transcription factors. These included multiple homeobox (HOX) gene families, oligodendrocytespecific basic helix-loop-helix transcription factors, forkhead box (FOX) family members, T-box transcription factors, and sex-determining region box (Fig. 3A and fig. S3 ). Upon siRNA-mediated knockdown of SP140 in macrophages, we observed a marked increase in chromatin accessibility at the TSS of the top 10% of genes occupied by SP140 ( Fig. 3B ). The genes that showed increased chromatin accessibility were both up-regulated and down-regulated [greater than twofold; false discovery rate (FDR), <0.05] upon knockdown of SP140, as determined by RNA sequencing (RNA-seq) (Fig. 3C) . However, genes with the greatest SP140 occupancy (top 5% of ChIP-seq peaks) showed a higher probability of being up-regulated upon depletion of SP140 (Fig. 3D ), whereas those genes that were down-regulated did not (Fig. 3D) , suggesting an indirect regulation of these genes by SP140.
We next focused on SP140 regulation of HOX genes, which include the HOXL, NKL, PRD, LIM, and SIX families, all of which were significantly overrepresented SP140 targets ( Fig. 3A and fig.  S3 ). Of all the HOX cluster genes, SP140 occupancy was highest at HOXA9 (Fig. 3E) , which is the most abundantly expressed HOX in HSCs, a known preserver of HSC self-renewal capacity, and is markedly down-regulated upon myeloid differentiation and macrophage activation (42) . HOXA9 is also a known repressor of several genes controlling macrophage differentiation and function (43) . At the HOXA cluster, SP140 preferentially occupied the "late" HOXA7 to HOXA13 cluster over the "early" HOXA1 to HOXA5 cluster in human M(IFN-) and M(IFN-+LPS 4h) macrophages (Fig. 3E ). As reported in differentiated mouse macrophages (44), we found that human M(IFN-) macrophages expressed high HOXA1 and low HOXA9 (Fig. 3F, inset) . A knockdown of SP140 resulted in a significant up-regulation of HOXA9 expression (Fig. 3G, looks like fig. S12A ), assigning a repressive role to SP140 occupancy at HOXA9. Consistent with this, human and mouse macrophages with a knockdown of SP140 and unrestrained HOXA9/Hoxa9 were incapable of fully reprogramming after exposure to LPS (Fig. 1) . Furthermore, depletion of both SP140 and HOXA9 restored expression of surface markers and cytokines, such as CD11b, CSFR1, and IL6, in human macrophages (Fig. 3H) . Thus, through repression of lineage-inappropriate genes and particularly through repression of HOXA9, SP140 promotes the emergence and preservation of macrophage activation status.
CD-associated polymorphisms within SP140 alter SP140 mRNA splicing
We examined the effect of the CD-associated SP140 SNPs on SP140 mRNA expression by RNA-seq of whole blood from individuals homozygous for the CD-risk SP140 SNP rs7423615 (SNP +/+ , red) and sexand age-matched controls (SNP −/− , black). Multiple SNPs are in perfect linkage disequilibrium (LD) (r 2 ≥ 0.90; D′ ≥ 0.98) with the top CDassociated intronic SNPs rs7423615 and rs6716753 (Fig. 4A) (16, 17) , including those associated with CLL (rs13397985) (18) and MS (rs10201872) (19), and hence may act coordinately (hereafter collectively referred to as SNP +/+ ). All of these SP140 SNPs are intronic, except for a single SNP in exon 7 (rs28445040) that was recently suggested to be the causal SNP (45) . Of the five known protein-coding mRNA isoforms of SP140 (Fig. 4B ), we observed a selective and significant elevation in the expression of the SP140 isoform ENST00000343805, which is devoid of exons 7 and 11, in peripheral blood from individuals carrying SP140 risk alleles (SNP (Fig. 4C) . The expression levels of a shorter SP140 isoform (ENST00000373645) was unaffected, implicating SNPs further downstream in causing defective splicing of SP140 (Fig. 4C) . The splicing defect driven by disease-associated SP140 SNPs was also observed in type I IFN and influenza-activated dendritic cells ( fig. S8) (47) . Furthermore, qPCR with exon-specific primers for SP140 exons 1 and 7 confirmed low levels of exon 7 but equal levels of exon 1 in Epstein-Barr virus (EBV)-transformed B cells homozygous for the SP140 risk SNPs (Fig. 4D) . Thus, our data show that the CD-associated SNPs within SP140 alter SP140 mRNA splicing, leading to elevated expression of the SP140 isoform ENST00000343805 devoid of exons 7 and 11 and an overall reduction in total SP140 mRNA expression.
Individuals carrying CD-associated SP140 SNPs have reduced and truncated SP140 protein
We next examined how the CD-associated SP140 SNPs that disrupted mRNA splicing affect SP140 protein levels. Exons 7 and 11 of SP140 do not code for any of the chromatin binding domains (SAND, PHD, and bromodomain) or nuclear localization sequence, but their exclusion is predicted to cause in-frame deletions of 26-and 33-amino acid peptide segments (~6.6 kDa) from the SP140 protein product. We assayed endogenous SP140 protein levels by immunoblot in EBVimmortalized B cell lines from individuals homozygous for rs7423615 and associated SNPs (+/+) and observed a truncation of nuclearlocalized SP140 protein isoforms (98-to 86-kDa isoforms) (Fig. 4E,  looks like fig. S9C ). Moreover, a pronounced loss of SP140 protein levels was evident (61 to 76% reduction in SNP +/+ cells from Caucasian individuals and 11% reduction in SNP +/+ cells from Sub-Saharan African individuals) (Fig. 4E) , whereas expression of the related SP110 protein, whose genomic locus is adjacent to SP140 and appears to share a divergent promoter, was unchanged (Fig. 4E) . Hence, individuals homozygous for CD-associated SNPs within SP140 have reduced protein levels of this epigenetic reader.
PBMCs carrying CD-associated SP140 SNPs have suppressed innate immune gene signatures
Given the identified role of SP140 in the maintenance of transcriptional programs that uphold macrophage differentiation and activation status and the mounting evidence of impaired homeostatic bacterial defense pathways in CD (26) differential genes were down-regulated compared with HCs (Fig. 5, D and E). Furthermore, only ~15% of the genes were differentially expressed in both SNP +/+ and SNP −/− compared with HCs, demonstrating clearly molecularly defined and stratified subsets of CD (Fig. 5C and fig. S10) (Fig. 5F) . Thus, CD patients homozygous for SP140 SNPs stratify from other CD patients not carrying SP140 SNPs by displaying suppressed innate immune signatures in a mixed population of PBMCs. genotype-specific differences. PBMCs from SP140 SNP +/+ patients produced significantly less IL6 and TNF transcript after stimulation with LPS or polyinosinic-polycytidylic acid (PolyI:C) (Fig. 6A) . We also observed significantly reduced secretion of cytokines IL-6, TNF, IL-12, IFN-, and IL-8, and CCL3 after TLR4 or TLR3 stimulation of PBMCs from CD + SP140 SNP +/+ patients and significantly reduced production LILRA5  DOCK4  CASP1  TNFAIP2  CEBPB  ATFS  ALCAM   MMP14  CD276  IL4I1   ELK1   IL27  TNFSF10  IFNG  TNFSF9  TNFSF15  BAZ1A  CCL1  TNFSF13B  CCL8  CXCL11  GPR132  CRLF2  DOT1L  GPR31  IRG1  TNIP3   CCRL2   IL1RN  CD274  CD80  NR4A3  RIPK2  IER3  IL10  ICAM1   BATF2  CCL2  CCL7  ADAM19  IL12RB2  XRN1  OSMR  TGFBR3  IL16  ZNF441  LY9  CX3CR1  MEF2C  CD180  LYL1   HDAC5  CD300A  LINGO3  LILRA1  LILRB2  CD163  CSF1R  TGFBI  AIF1  CD36  CLEC7A  CMKLR1  CD209  CCR1  TLR4 patients displayed significantly enhanced production of IL-13, a type 2 cytokine involved in both beneficial tissue repair and pathological fibrosis (48), after TLR4 or TLR3 activation (Fig. 6D) . Hence, a genetic loss of SP140 prevents proper transcriptional reprogramming in response to TLR activation. As a result, CD patients homozygous for CD-associated SNPs within SP140 generate compromised innate immune responses, a known contributing factor to intestinal imbalance and inflammation (26), compared with other CD patients not carrying the SP140 CD-risk allele.
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Hematopoietic knockdown of mouse Sp140 exacerbates DSS-colitis
To determine whether a deficiency of Sp140 can drive intestinal inflammation in vivo, we performed an inducible shRNA-mediated hematopoietic depletion of Sp140 in mice. Bone marrow that was lentivirally transduced with shSp140 or a control shRNA under an isopropyl--d-thiogalactopyranoside (IPTG)-inducible promoter was transferred to irradiated congenic hosts, and IPTG was administered to trigger shRNA transcription and Sp140 depletion after full reconstitution of the hematopoietic system (Fig. 7A) . Ficoll-isolated circulating PBMCs from mice reconstituted with shSp140-transduced bone marrow were CD45.1 + (Fig. 7B ) and Sp140-depleted (Fig. 7C) . Furthermore, an immunoblot of splenic lysates confirmed hematopoietic depletion of Sp140 (Fig. 7D, looks like fig. S12C ). We subjected the mice to a DSS model of colitis, a useful model for studying the contribution of the innate immune system to IBD. Mice with a hematopoietic-specific depletion of Sp140 (Fig. 7 , B and C) displayed exacerbated colitis symptoms, as evidenced by significantly more weight loss (Fig. 7E ), higher disease activity scores (Fig. 7F) , increased fecal lipocalin (Fig. 7G) , and reduced colon length (Fig. 7, H and I), compared with control mice. In addition, SP140-depleted mice had increased intestinal permeability, as measured by fluorescein isothiocyanate (FITC)-dextran in the blood 4 hours after gavage administration (Fig. 7J) , as well as increased bacterial load in mesenteric lymph nodes (Fig. 7K) . Colonic explants from SP140-depleted mice had elevated cytokine production (Fig. 7L) , and SP140-depleted mice had significantly increased serum IL-6 (Fig. 7M) . Furthermore, SP140-depleted mice had significantly higher histopathology scores with a more severe loss of goblet cell morphology, a diffuse lymphocytic infiltrate to the level of the lamina submucosa, a thickening of the mucosa, and extensive edema (Fig. 7, N and O) . Thus, expression and function of immune-restricted Sp140 is a requirement for intestinal homeostasis, and a loss of Sp140 drives intestinal inflammation. TNF pg/ml IL-1 pg/ml IL-12 pg/ml IL-15 pg/ml IL-8 pg/ml CCL3 pg/ml IL-6 pg/ml IFN pg/ml TNF pg/ml IL-1 pg/ml IL-12 pg/ml IL-15 pg/ml IL-8 pg/ml CCL3 pg/ml Lower SP140 expression in intestinal biopsies correlates with better response to anti-TNF therapy Given that SP140 SNP CD patients stratified from other CD patients by ineffective innate immunity and reduced cytokine production from PBMCs, we next examined whether SP140 expression correlated with innate cytokine levels in the intestine of IBD patients and their responsiveness to anti-TNF therapy. About 20% of patients are primary nonresponders to anti-TNF therapy, and 31 to 38% will eventually fail therapy. One predictor of responsiveness is a lower baseline expression of TNF and other cytokines in the intestine (49) . We mined transcript expression data of intestinal biopsies taken before or after anti-TNF (infliximab) therapy (50) and found significantly lower expression of SP140 in intestinal biopsies taken before treatment in patients who ultimately responded to anti-TNF (Fig. 8A) . After anti-TNF treatment, SP140 levels were further reduced in anti-TNF responders but remained elevated in anti-TNF nonresponders (Fig. 8A) . Lower SP140 mRNA levels in intestinal biopsies of TNF responders were independent of the immune cell composition (fig. S11 ). We also found lower levels of many innate immune cytokines in intestinal biopsies of patients with low SP140 expression compared with patients with high SP140 expression (Fig. 8B) . Moreover, Gene Ontology analysis of all genes that positively correlated with SP140 expression in intestinal biopsies (r 2 > 0.75) revealed gene signatures associated with immune cell activation (Fig. 8C) . Thus, SP140 levels in intestinal biopsies correlate with the intestinal inflammatory state and are predictive of responsiveness to anti-TNF therapy.
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DISCUSSION
Our current understanding of disrupted epigenetic programs in immunemediated disease is limited. Here, we report on SP140, a previously uncharacterized immune-restricted epigenetic reader that has previously reported SNPs that associate with CD (16, 17) , CLL (18), and MS (19). We show that individuals bearing CD-associated SP140 SNPs, most of which are intronic and in perfect LD with SP140 SNPs associated with CLL and MS, have alterations in SP140 mRNA splicing that ultimately result in loss of SP140 protein, consistent with the findings from a recent publication (45) . Consequently, CD patients deficient in this epigenetic reader exhibited hyporesponsive innate immune responses to bacteria or viral ligands that stratified them from other CD patients. The development of IBD is influenced by host genetics as well as dysbiosis and impaired handling of commensal bacteria and virus communities (16, 26) . Our data now provide evidence that an inability to interpret the immune epigenome due to loss of SP140 contributes to IBD. Furthermore, it adds SP140 to a number of other IBD-associated genes (NOD2, ATG16L1, GPR65, and AIM2) that drive innate immunity in the intestine and whose loss or variation results in impaired barrier defense, decreased cytokine production, and an inability to maintain gut microbial balance, which ultimately enhances intestinal inflammation (26, (28) (29) (30) 51) .
We demonstrate in human M(IFN-) and M(IFN-+LPS) macrophages that the bromodomain/PHD/SAND domain-containing SP140 interacts with chromatin, predominantly at promoters and primarily at silenced, lineage-inappropriate genes marked by H3K27me3, to orchestrate macrophage transcriptional programs both at steady state and in response to cytokines and microbes. The highest amount of SP140 was found at HOX genes, particularly HOXA9, a known promoter of stem-like state in HSCs and an inhibitor of macrophage differentiation (42, 43, 52) . Our work thus reveals an essential role for the epigenome reader SP140 in the coordination of HOX gene expression in mature macrophages. Many other epigenetic regulators also contribute to the management of hematopoietic HOX gene expression (39) . These include two opposing groups of histone methyltransferases: MLL (mixedlineage leukemia) and the EZH2 subunit of PRC2, as well as the H3K27me3 demethylase JMJD3. Similar to what we observed after SP140 knockdown, genetic deletion or chemical inhibition of JMJD3 resulted in significantly altered macrophage activation after exposure to helminth or bacteria (53, 54) . Further work is warranted to understand how the elaborate epigenetic regulation of HOX genes functions in a range of macrophage tissue subtypes and precisely at what stage of cellular differentiation and/or activation. We also found SP140 occupancy on several other lineage-determining transcription factors that are repressed in macrophages (the oligodendrocyte-specific basic helix-loop-helix transcription factors OLIG1 to OLIG3; the FOX family members FOXB1, FOXC2, FOXD2, FOXD3, and FOXG1; and the paired box proteins PAX2, PAX3, PAX5, PAX6, PAX8, and PAX9). Therefore, we propose that by suppressing multiple lineage-inappropriate genes in differentiated macrophages, SP140 coordinates transcriptional output that defines the macrophage state, particularly after exposure to cytokines and microbial pathogen-associated molecular patterns. Given that our study is the first to examine the function of the epigenetic reader SP140 in any detail, many questions of course remain unanswered. For instance, it remains unclear which reading domains (bromodomain, PHD, and/or SAND) render specificity of SP140 binding to chromatin. Furthermore, a nucleosome affinity purification assay did not identify SP140 as a direct interactor of methylated H3K27 nucleosomes, at least in HeLa cells (55) . Therefore, SP140 may dock to repressed loci in macrophages via other yet-to-be identified histone modifications. Moreover, we found SP140 to also occupy active enhancers, the repertoire of which is highly cell type-and activation statespecific (37, 56) . Hence, whether SP140 is solely a repressor or whether its function is altered when docked to enhancers, particularly through the bromodomain, ultimately to establish macrophage identity, needs to be investigated. Another limitation of our study is that experiments were performed in either mouse bone marrow-derived macrophages, human peripheral blood-derived macrophages, or PBMCs stimulated with bacterial or viral ligands. Future studies that probe the function of SP140 in immune cells that reside specifically within the intestine may provide greater insight into the precise role of this epigenetic reader in homeostatic immunity toward commensal microbes. Also, SP140 function in other immune cell types could certainly contribute to CD and should be considered. However, because SP140 shows only 54% amino acid homology between mouse and human, studies of this protein solely in mice will have limitations. In addition, given the association of SP140 SNPs with CLL and MS and the high expression of SP140 in B cells and dendritic cells, the investigation of SP140 function in these cells is warranted. However, microbiome alterations that affect innate immune pathways have been observed in MS patients (57) , and other MS-associated mutations (e.g., in TNFRSF1A) block TNF, mirroring the clinical experience of MS patients where anti-TNF therapies can exacerbate disease (58) . Therefore, a genetic deficiency of SP140 could conceivably contribute to MS through a reduction in TNF and other innate cytokines and merits investigation. Last, given the growing evidence that epigenetic reprogramming dictates antigen-independent trained immunity and tolerance (6, 34) , genetic variants of SP140 or other epigenome regulatory enzymes may have a broader impact on an individual's immune status than currently appreciated.
Together, our findings identify the epigenetic reader SP140 as a critical regulator of macrophage function and innate immunity that enables intestinal homeostasis. Our work also uncovers a direct link between a loss of SP140 through genetic variation and IBD. Given the enthusiasm surrounding the therapeutic tractability of histone binding domains by chemical inhibitors (7), it is worth noting that our results suggest that targeting this particular bromodomain-containing epigenetic reader may not be desirable, at least in subsets of CD (or CLL or MS) patients bearing SP140 SNPs. Furthermore, this work has important implications for understanding how alterations in the epigenome and the interpretation of the epigenome via readers can drive immune-mediated disease, which may inform better therapeutic strategies.
MATERIALS AND METHODS
Study design
The human study population consisted of adult patients enrolled in the Prospective Registry in IBD Study at Massachusetts General Hospital (PRISM), a single-center ongoing patient registry that aims to understand the causes of IBD and factors affecting disease progression. Patients were approached during their regularly scheduled clinic visits at the Massachusetts General Hospital (MGH) Crohn's and Colitis Center. Study research coordinators obtained consent, and medical history was obtained and confirmed by review of the electronic medical record. Animal studies were conducted under protocols approved by the MGH Institutional Animal Care and Use Committee. All in vitro experiments with primary mouse or human macrophages included two to six biological replicates performed in triplicate, as indicated in the figure legends. All in vivo experiments were performed independently two times, with four to seven animals per group.
SP140 ChIP-seq and analysis
Sixty million naïve or LPS-stimulated (100 ng/ml for 4 hours) human M(IFN-) macrophages were cross-linked with 1% formaldehyde (Fisher Scientific) for 10 min at room temperature. Formaldehyde was quenched with 1.25 M glycine for 5 min at room temperature. Cells were scraped, washed in cold phosphate-buffered saline (PBS) containing protease inhibitors, and frozen. Nuclei were isolated using the truChIP kit (Covaris Inc.), and chromatin was sheared at 4°C, 140 W, and 200 cycles per burst with 10% duty factor for 8 min and 30 s (Covaris Inc.). Input fraction was saved (0.7%), and the remaining sheared chromatin was used for ChIP with a polyclonal SP140 antibody (HPA006162, Sigma) or an immunoglobulin G isotype control (Millipore) in immunoprecipitation buffer [0.1% Triton X-100, 0.1 M tris-HCl (pH 8), 0.5 mM EDTA, and 0.15 M NaCl in 1× Covaris D3 buffer] at 4°C, rotating overnight, followed by incubation with Dynabeads Protein G (10003D, Life Technologies) for 4 hours. The chromatin-bead-antibody complexes were then washed sequentially with three wash buffers of increasing salt concentrations and TE buffer. Chromatin was eluted using 1% SDS in Tris-EDTA. Cross-linking was reversed by incubation with ribonuclease A (Roche) for 1 hour at 37°C, followed by an overnight incubation at 65°C with Proteinase K (Roche). DNA was purified with the QIAquick PCR Purification Kit (28104, Qiagen). Libraries of input DNA and ChIP DNA were prepared from gel-purified >300-base pair (bp) DNA fragments. Samples were multiplexed and sequenced on an Illumina HiSeq 2500 in the rapid mode to obtain 50-bp single-ended reads.
Peak calling was carried out with bcbio_nextgen (http://gihub.com/ chapmanb/bcbio-nextgen). Briefly, after quality assessment using FastQC (www.bioinformatics.babraham.ac.uk/projects/fastqc/), reads were trimmed using cutadapt version 1.9.1 (http://cutadapt.readthedocs. io/en/stable/) with a quality cutoff of 5 to remove low-quality 3′ ends from reads, retaining reads with a minimum length of 25 bp. Trimmed reads were mapped against the UCSC hg19 reference genome using Bowtie 2 version 2.2.7 (59) with default parameters. Alignments were sorted and filtered to retain only uniquely mapping reads using sambamba version 0.5.9 (60) . ChIP peaks were called using MACS2 version 2.1.0 with broad option (61) for the SP140 M(IFN-) and M(IFN-+LPS 4h) ChIP samples versus input control DNA. Furthermore, relevant H3K27ac (GSE54972), H3K4me1 (GSE31621), H3K4me3 (GSM1146439), and H3K27me3 (GSM1625982 and GSM1625986) ChIP-seq data from human monocyte-derived macrophages were obtained from the Gene Expression Omnibus and analyzed in the same way. We used the broad option for H3K27me3 chip data and default narrow peak parameters for H3K27ac, H3K4me1, and H3K4me3. In the case of H3K27ac, we followed similar preprocessing steps to those described in a previously published paper (62): (i) paired-end files were converted to single end by retaining one read of each proper pair and removing improperly paired reads, (ii) regions corresponding to ENCODE blacklisted sites were removed, and (iii) replicates were pooled by merging the BAM files before peak calling. Similarly, replicates for H3K4me3 were pooled, and peaks were called on the merged BAM files. To filter the set of peak calls for each data set and obtain higher confidence peaks, we plotted histograms of the fold enrichment (FE) values and defined the background to be the mode of the FE values, that is, the value that occurs most often. This resulted in a cutoff of 3 for H3K27me3, 3.5 for SP140 M(IFN-) and SP140 M(IFN-+LPS 4h), 5 for H3K27ac and H3K4me1, and 6 for H3K4me3. and subjected to ATAC-seq as previously described (40) . Briefly, 50,000 cells were pelleted, resuspended in 50 l of lysis buffer [10 mM tris-HCl (pH 7.4), 3 mM MgCl 2 , 10 mM NaCl, and 0.1% NP-40 (CA-630, IGEPAL)], and immediately centrifuged at 500g for 10 min at 4°C. The nuclei pellets were resuspended in 50 l of transposition buffer (25 l of 2× 13 tagmentation DNA buffer, 22.5 l of dH 2 O, and 2.5 l of Illumina Tn5 transposase) and incubated for 30 min at 37°C. Transposed DNA was purified with the MinElute PCR Purification Kit (Qiagen) and eluted in 10 l of elution buffer (Qiagen). Barcoded ATAC-seq libraries were prepared as previously described and sequenced on an Illumina HiSeq 2500.
Assay for transposase-accessible chromatin
Hematopoietic depletion of Sp140 in mice
To allow for temporal control of shRNA expression in vivo, we used the TRC905 lentiviral vector (Broad Institute), whereby shRNA expression is under the control of an IPTG-inducible promoter. In this system, IPTG binds to the Lac I repressor protein, preventing it from binding to three Lac O repressor binding sites surrounding the U6 promoter required for shRNA expression (63) . The shRNA target 21-nucleotide oligomer sequences were as follows: shGFP, GCAAGCTGACCCT-GAAGTTCAT; mouse shSP140, GATGATTACTCTTGGTCATAT. Plasmids were purified with a QIAprep Maxiprep kit (Qiagen) and transfected into human embryonic kidney-293T cells along with pCMVdR8.2 dvpr and pCMV-VSVG for the production of lentivirus. Bone marrow progenitor cells obtained from CD45.1 C57BL/6 donor mice were placed in 24-well tissue culture dishes (1 × 10 6 cells per well) and infected with 400 l of unconcentrated shRNA lentiviral supernatant and polybrene (7.5 g/ml) on day 1. Cells were spun for 30 min at 800g and placed in fresh medium containing 15% fetal bovine serum, IL-3 (20 ng/ml), IL-6 (50 ng/ml), and stem cell factor (SCF) (50 ng/ml). On day 2, the bone marrow cells were reinfected again. On day 3, puromycin (3 g/ml) was added to the growth medium. On day 4, the cells were harvested and washed twice in PBS. For bone marrow transplantation, CD45.2 C57BL/6 recipient mice were irradiated with 131Cs at 10 gray on day 0 and injected retro-orbitally with 2.5 × 10 6 CD45.1 lentivirustransduced bone marrow in 200 l of Dulbecco's modified Eagle's medium, after which the mice were monitored for 6 weeks to allow for immune reconstitution. Six weeks after transplantation, blood was analyzed for reconstitution by measuring CD45.1 by flow cytometry. Next, we administered IPTG (1 mg intraperitoneally and 10 mM IPTG into the drinking water for 1 week) to induce the shRNA. All mice were maintained under specific pathogen-free conditions at the animal facility of MGH under a protocol approved by the Institutional Animal Care and Use Committee.
Statistical analysis
Comparisons and statistical tests were performed as indicated in each figure legend. Briefly, for comparisons of multiple groups over time or with two variables, a two-way analysis of variance (ANOVA) was used and corrected for multiple post hoc comparisons, comparing all groups to each other, all groups to a control, or selected groups to each other. For comparisons of multiple groups with only one variable, a one-way ANOVA was performed and corrected for multiple post hoc comparisons. For comparisons of two groups, two-tailed paired or unpaired t tests were used, except where indicated. Statistical analyses were performed in the GraphPad Prism software. A P value of less than 0.05 was considered significant, denoted as *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, and ****P < 0.0001 for all analyses. Correlation analyses for SP140 mRNA expression in individuals carrying none, one, or two alleles of SP140 SNPs and SP140 ChIP-seq data with various histone modifications were performed with Spearman ranking coefficients. FDR correction was performed for all RNA-seq data.
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